Lewy body pathology in late-onset familial Alzheimer's disease: A clinicopathological case series

Journal of Alzheimer's Disease

Volumn 9, Issue 3, 2006, Pages 235-242

  Tsuang, Debby W ^a,b,c   Riekse, Robert G ^b   Purganan, Kristina M ^a,b   David, Andrew C ^a,b   Montine, Thomas J ^b   Schellenberg, Gerard D ^a,b   Steinbart, Ellen J ^a,b   Petrie, Eric C ^a,b   Bird, Thomas D ^a,b   Leverenz, James B ^a,b  

^a Veterans Puget Sound Health Care System   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Alpha synuclein; Alzheimer's disease; Amygdala; Lewy body

Indexed keywords

ALPHA SYNUCLEIN; EOSIN; HEMATOXYLIN;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 33747395409     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9302     Document Type: Article

References (26)

1. C.F. Lippa, H. Fujiwara, D.M. Mann, B. Giasson, M. Baba, M.L. Schmidt, L.E. Nee, B. O'Connell, D.A. Pollen, P. St George-Hyslop, B. Ghetti, D. Nochlin, T.D. Bird, N.J. Cairns, V.M. Lee, T. Iwatsubo and J.Q. Trojanowski, Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes, Am J Pathol 153 (1998), 1365-1370.
2. C.F. Lippa, M.L. Schmidt, V.M. Lee and J.Q. Trojanowski, Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease, Ann Neurol 45 (1999), 353-357.
3. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes and M. Goedert, Alpha-synuclein in Lewy bodies, Nature 388 (1997), 839-840.
4. E. Gomez-Tortosa, K. Newell, M.C. Irizarry, J.L. Sanders and B.T. Hyman, alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining, Acta Neuropathol (Berl) 99 (2000), 352-357.
5. R.L. Hamilton, Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry, Brain Pathol 10 (2000), 378-384.
6. J.B. Leverenz, M. Fishel, E. Peskind, T. Montine, D. Nochlin, E.J. Steinbart, M.R. Raskind, G.D. Schellenberg, T.D. Bird and D.W. Tsuang, Lewy body pathology in familial AD: Evidence for disease and mutation specific pathologic phenotype, Arch Neurol 63 (2006), 370-376..
7. C.K. Rosenberg, M.A. Pericak-Vance, A.M. Saunders, J.R. Gilbert, P.C. Gaskell and C.M. Hulette, Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation, Acta Neuropathol (Berl) 100 (2000), 145-152.
8. J.M. Olichney, D. Galasko, D.P. Salmon, C.R. Hofstetter, L.A. Hansen, R. Katzman and L.J. Thal, Cognitive decline is faster in Lewy body variant than in Alzheimer's disease, Neurology 51 (1998), 351-357.
9. D. Aarsland, I. Litvan, D. Salmon, D. Galasko, T. Wentzel-Larsen and J.P. Larsen, Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease, J Neurol Neurosurg Psychiatry 74 (2003), 1215-1220.
10. C. Ballard, J. O'Brien, C.M. Morris, R. Barber, A. Swann, D. Neill and I. McKeith, The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease, Int J Geriatr Psychiatry 16 (2001), 499-503.
11. M.L. Kraybill, E.B. Larson, D.W. Tsuang, L. Teri, W.C. McCormick, J.D. Bowen, W.A. Kukull, J.B. Leverenz and M.M. Cherrier, Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both, Neurology 64 (2005), 2069-2073.
12. D. Galasko, T. Saitoh, Y. Xia, L.J. Thal, R. Katzman, L.R. Hill and L. Hansen, The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease, Neurology 44 (1994), 1950-1951.
13. D.W. Tsuang, R.K. Wilson, O.L. Lopez, E.K. Luedecking-Zimmer, J.B. Leverenz, S.T. DeKosky, M.I. Kamboh and R.L. Hamilton, Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease, Neurology 64 (2005), 509-513.
14. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, D.P. Salmon, J. Lowe, S.S. Mirra, E.J. Byrne, G. Lennox, N.P. Quinn, J.A. Edwardson, P.G. Ince, C. Bergeron, A. Burns, B.L. Miller, S. Lovestone, D. Collerton, E.N. Jansen, C. Ballard, R.A. de Vos, G.K. Wilcock, K.A. Jellinger and R.H. Perry, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, Neurology 47 (1996), 1113-1124.
15. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol (Berl) 82 (1991), 239-259.
16. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle and L. Berg, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41 (1991), 479-486.
17. D.W. Tsuang, A.M. Dalan, C.J. Eugenio, P. Poorkaj, P. Limprasert, A.R. La Spada, E.J. Steinbart, T.D. Bird and J.B. Leverenz, Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families, Arch Neurol 59 (2002), 1622-1630.
18. J.E. Duda, B.I. Giasson, M.E. Mabon, V.M. Lee and J.Q. Trojanowski, Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases, Ann Neurol 52 (2002), 205-210.
19. J.E. Hixson and D.T. Vernier, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lipid Res 31 (1990), 545-548.
20. M. Emi, L.L. Wu, M.A. Robertson, R.L. Myers, R.A. Hegele, R.R. Williams, R. White and J.M. Lalouel, Genotyping and sequence analysis of apolipoprotein E isoforms, Genomics 3 (1988), 373-379.
21. B.T. Hyman and J.Q. Trojanowski, Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease, J Neuropathol Exp Neurol 56 (1997), 1095-1097.
22. C.F. Lippa, M.L. Schmidt, V.M. Lee and J.Q. Trojanowski, Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease, Arch Neurol 58 (2001), 1817-1820.
23. W. Marui, E. Iseki, T. Nakai, S. Miura, M. Kato, K. Ueda and K. Kosaka, Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies, J Neurol Sci 195 (2002), 153-159.
24. H. Braak, E. Ghebremedhin, U. Rub, H. Bratzke and K. Del Tredici, Stages in the development of Parkinson's disease-related pathology, Cell Tissue Res 318 (2004), 121-134.
25. E.M. Wijsman, E.W. Daw, C.E. Yu, H. Payami, E.J. Steinbart, D. Nochlin, E.M. Conlon, T.D. Bird and G.D. Schellenberg, Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2, Am J Hum Genet 75 (2004), 398-409.
26. Y. Trembath, C. Rosenberg, J.F. Ervin, D.E. Schmechel, P. Gaskell, M. Pericak-Vance, J. Vance and C.M. Hulette, Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease, Acta Neuropathol (Berl) 105 (2003), 484-488.